|
2.8 ETIOLOGIE - CONTRACEPTIFS, THS
|
|
|
|
|
3.1 PRÉVENTION - TABAC
|
|
|
Anti-smoking advocates bemoan “faltering” pace of FDA action [AP]
|
|
|
|
|
|
Efforts to bolster cigarette warnings and ban harmful ingredients have been stymied by tobacco companies. And the pace of progress is so slow that the FDA now faces lawsuits from its traditional allies: anti-smoking groups who are suing the agency to take action.
|
|
|
|
|
|
|
|
3.1.1 PRÉVENTION - TABAC - E-CIGS
|
|
|
The Mysterious Vaping Illness That’s ‘Becoming an Epidemic’ [NY Times]
|
|
|
|
|
|
Dr. Scott Gottlieb, the former commissioner of the Food and Drug Administration, said he suspected a link to illicit products — perhaps related to ingredients including THC — because the main manufacturers of e-cigarettes had not suddenly altered their ingredients on a wide scale.
|
|
|
|
|
|
|
|
|
CDC probes lung illnesses linked to e-cigarette use [Reuters]
|
|
|
|
|
|
The CDC is working with health departments in Wisconsin, Illinois, California, Indiana and Minnesota on the investigation. Since June 28, states have reported 94 possible cases of severe lung illness tied to vaping, primarily among teenagers and young adults, according to a CDC statement on Saturday.
|
|
|
|
|
|
|
|
4. DÉPISTAGE, DIAGNOSTIC ET PRONOSTIC
|
|
|
|
4.15 DÉP., DIAG. & PRONO. - IMAGERIE
|
|
|
|
4.2 DÉP., DIAG. & PRONO. - GÉNOME
|
|
|
|
|
5. TRAITEMENTS
|
|
|
|
5.10 TRAITEMENTS - ESSAIS
|
|
|
|
|
|
5.12.1 IMMUNOTHÉRAPIES - PARTENARIATS
|
|
|
|
5.12.2 IMMUNOTHÉRAPIES - CAR-T, THÉRAPIES CELLULAIRES
|
|
|
Adaptimmune pens backloaded deal to access T-cell tech [Fierce Biotech]
|
|
|
|
|
|
Noile-Immune is a Japanese chimeric antigen receptor T-cell (CAR-T) player built on technology developed by Yamaguchi University’s Koji Tamada. In mice, CAR-T cells engineered using the technology to express IL-7 and CCL19 performed better than conventional CAR-T therapies and were associated with increased infiltration of dendritic cells and T cells into tumors.
|
|
|
|
|
|
|
5.12.3 IMMUNOTHÉRAPIES-COMBINAISONS
|
|
|
|
|
|
|
|
5.12.6 IMMUNOTHÉRAPIES - AMM
|
|
|
|
|
|
|
5.13 WCLC
|
|
|
|
5.17 TRAITEMENTS - RADIOTHÉRAPIE
|
|
|
|
5.2.1 PHARMA - PARTENARIATS
|
|
|
|
|
5.2.2 PHARMA - FUSIONS & ACQUISITIONS
|
|
|
|
5.2.4 PHARMA - ABBVIE
|
|
|
|
|
|
|
5.2.5 PHARMA - GSK
|
|
|
|
|
|
|
5.3 TRAITEMENTS - FDA, EMA, NICE...
|
|
|
|
5.3.4 TRAITEMENTS - AMM (FDA, EMA,...)
|
|
|
|
|
|
|
|
FDA approves Celgene's bone marrow cancer treatment [Reuters]
|
|
|
|
|
|
Inrebic belongs to a class of drugs known as JAK inhibitors that work by blocking inflammation-causing Janus kinases enzymes. It will compete with Incyte Corp’s Jakafi, also a JAK inhibitor, which was approved in 2011 for treating the same condition.
|
|
|
|
|
|
|
|
5.4 TRAITEMENTS - ECONOMIE
|
|
|
|
6. LUTTE CONTRE LES CANCERS
|
|
|
|
6.1 OBSERVATION
|
|
|
|
|
6.10 POLITIQUES
|
|
|
|
6.11 PATIENTS
|
|
|
|
6.6 PUBLICATIONS
|
|
|
|
|
6.7.1 IA/BIOINFORMATIQUE
|
|
|
|
6.9 CONTROVERSES
|
|
|
Scientists Avoid Bias When They Know They're Being Tested [Wired]
|
|
|
|
|
|
It's possible to set up artificial test situations that are better controlled, but people's behavior changes when they know they're being tested. That is precisely the message that's driven home by a new paper that looks at gender bias in the awarding of research positions in France.
|
|
|
|
|
|